BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1301 related articles for article (PubMed ID: 34019087)

  • 1. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic Treatment.
    Herrin J; Abraham NS; Yao X; Noseworthy PA; Inselman J; Shah ND; Ngufor C
    JAMA Netw Open; 2021 May; 4(5):e2110703. PubMed ID: 34019087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age.
    Abraham NS; Noseworthy PA; Inselman J; Herrin J; Yao X; Sangaralingham LR; Cornish G; Ngufor C; Shah ND
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):337-346.e19. PubMed ID: 31108228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldan V; Vicente V; Valdés M; Marín F; Lip GYH
    Thromb Haemost; 2017 Oct; 117(10):1848-1858. PubMed ID: 28799620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitor Utilization in Veteran Patients on Combined Antithrombotic Therapy and Validation of Simplified Bleeding Risk Score.
    Patil T; Murphy K; Woodard L; Lebrecht M
    Pharmacotherapy; 2020 Dec; 40(12):1219-1227. PubMed ID: 33073362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
    J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
    BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban).
    Lv M; Jiang S; Wu T; Huang N; Chen X; Chen C; Zhang J
    Br J Clin Pharmacol; 2023 Jan; 89(1):253-260. PubMed ID: 35971682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
    Brown JD; Goodin AJ; Lip GYH; Adams VR
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction Score for Anticoagulation Control Quality Among Older Adults.
    Lin KJ; Singer DE; Glynn RJ; Blackley S; Zhou L; Liu J; Dube G; Oertel LB; Schneeweiss S
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.
    Roldán V; Marín F; Fernández H; Manzano-Fernandez S; Gallego P; Valdés M; Vicente V; Lip GYH
    Chest; 2013 Jan; 143(1):179-184. PubMed ID: 22722228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.
    Wu S; Lv M; Ma F; Feilong Z; Fang G; Zhang J
    Eur J Clin Pharmacol; 2023 Sep; 79(9):1195-1204. PubMed ID: 37392366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.
    Staerk L; Lip GY; Olesen JB; Fosbøl EL; Pallisgaard JL; Bonde AN; Gundlund A; Lindhardt TB; Hansen ML; Torp-Pedersen C; Gislason GH
    BMJ; 2015 Nov; 351():h5876. PubMed ID: 26572685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
    Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M
    Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Hemoccult Testing Before Therapeutic Anticoagulation in Venous Thromboembolism.
    Urbas R; Badri M; Albert NE; Prince C; Mayilvaganan B
    South Med J; 2017 May; 110(5):375-380. PubMed ID: 28464181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
    Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Garcia DA; Fisher DA; Mulder H; Wruck L; De Caterina R; Halvorsen S; Granger CB; Held C; Wallentin L; Alexander JH; Lopes RD
    Am Heart J; 2020 Mar; 221():1-8. PubMed ID: 31896036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer.
    Truong B; Zheng J; Hornsby L; Fox B; Chou C; Qian J
    Cardiovasc Toxicol; 2024 Apr; 24(4):365-374. PubMed ID: 38499940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.